For TIA patients suffering from type 2 diabetes, blood glucose levels are mainly managed through lifestyle modifications, along with the use of metformin, sodium‐glucose cotransporter inhibitors, and GLP‐1 receptor agonists [17]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.